On May 21, 2019 LGM Pharma attended the BioFlorida Palm Beach/Treasure Coast Event and learned about Max Planck Florida Institute for Neuroscience’s latest research initiatives from Research Group Leader Jason Christie, PhD.
The event also featured Cytonics Corporation. Cytonics has raised over $18M to-date in pursuance of their drug development program, and recently completed a Regulation CF crowdfunding campaign. Cytonics intends to use the funds to begin pre-clinical trials for their recombinant biologic therapy for osteoarthritis.
BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.
Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.